Market closed
Neumora Therapeutics/$NMRA
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Neumora Therapeutics
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.
Ticker
$NMRA
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
109
Website
NMRA Metrics
BasicAdvanced
$391M
-
-$1.86
-
-
Price and volume
Market cap
$391M
52-week high
$11.57
52-week low
$1.83
Average daily volume
4.1M
Financial strength
Current ratio
10.982
Quick ratio
10.752
Total debt to equity
0.856
Management effectiveness
Return on assets (TTM)
-34.92%
Return on equity (TTM)
-70.48%
Valuation
Price to book
1.21
Price to tangible book (TTM)
1.21
Price to free cash flow (TTM)
-2.013
Growth
Earnings per share change (TTM)
-59.63%
3-year earnings per share growth (CAGR)
-45.86%
NMRA News
AllArticlesVideos
Neumora Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - NMRA
Business Wire·2 weeks ago
Neumora's depression drug fails trial, sinking shares
CNBC Television·2 weeks ago
Neumora Therapeutics shares plummet as Phase 3 depression drug trial disappoints
Proactive Investors·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Neumora Therapeutics stock?
Neumora Therapeutics (NMRA) has a market cap of $391M as of January 15, 2025.
What is the P/E ratio for Neumora Therapeutics stock?
The price to earnings (P/E) ratio for Neumora Therapeutics (NMRA) stock is 0 as of January 15, 2025.
Does Neumora Therapeutics stock pay dividends?
No, Neumora Therapeutics (NMRA) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Neumora Therapeutics dividend payment date?
Neumora Therapeutics (NMRA) stock does not pay dividends to its shareholders.
What is the beta indicator for Neumora Therapeutics?
Neumora Therapeutics (NMRA) does not currently have a Beta indicator.